Analysis reveals strong demand for herbal supplements in traditional medicine, indicating focused portfolio strategies may enhance market success.
: Objective: This paper analyzes a multi-country sheet of Ayurvedic products to quantify demand across continents, identify leading countries and product clusters, and generate short- to mid‑term projections under two growth scenarios. Background: Global interest in traditional and herbal products has accelerated, with WHO backing a dedicated Global Traditional Medicine Centre and governments digitizing knowledge assets; market estimates for Ayurveda and herbal supplements indicate strong growth trajectories. Methods: We cleaned the dataset, aggregated Grand Total values at continent and country levels, and compared product portfolios via a continent–product heatmap. We then modelled forward projections (2025–2030) using compound annual growth rates (CAGR) representing (a) a conservative herbal‑supplements path (8.9%) and (b) a high‑growth Ayurveda path (27.2%). Results: The sheet indicates pronounced geographic concentration of demand, with a small set of countries contributing a large share of the Grand Total. Product mix differs materially by continent, suggesting localization of preferences and supply chains. Under the conservative scenario the global total approximately doubles over 7 years, whereas the high‑growth path yields a 4–5× expansion. Implications: Distinct product–continent niches (e.g., turmeric extract dominance in select regions; emerging interest in ashwagandha and boswellia) can guide portfolio and sourcing strategies. Conclusions: Combining granular sheet analytics with externally validated growth ranges offers a transparent, scenario‑based view of opportunity while flagging data limitations (single snapshot, no time series).
No takes yet. Share an insight, caveat, or question.
N. Dave (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: